Effects of the space flight environment on the immune system

Reviews on Environmental Health

Volumn 18, Issue 1, 2003, Pages 1-17

  Sonnenfeld, Gerald ^a   Butel, Janet S ^b   Shearer, William T ^b  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bedrest; Hindlimb unloading; Immune system; Infection; Space flight; Virus

Indexed keywords

CELLULAR IMMUNITY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MICROGRAVITY; NUTRITION; REVIEW; SLEEP DISORDER; SPACE FLIGHT; STRESS; ANIMAL; BIOSYNTHESIS; CELL CULTURE; COSMOS PROJECT; CULTURE TECHNIQUE; FLIGHT EXPERIMENT; HUMAN; LYMPHOCYTE ACTIVATION; MANNED; NASA DISCIPLINE REGULATORY PHYSIOLOGY; NON-NASA CENTER; PHYSIOLOGY; RADIATION EXPOSURE; SHORT DURATION; STS SHUTTLE PROJECT; UNMANNED;

ANIMALIA; MAMMALIA;

CYTOKINE;

NASA DISCIPLINE REGULATORY PHYSIOLOGY; NON-NASA CENTER;

COSMOS PROJECT; FLIGHT EXPERIMENT; MANNED; SHORT DURATION; STS SHUTTLE PROJECT; UNMANNED;

ANIMALS; CELLS, CULTURED; CULTURE TECHNIQUES; CYTOKINES; HUMANS; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; SPACE FLIGHT;

EID: 0141432227     PISSN: 00487554     EISSN: None     Source Type: Journal    
DOI: 10.1515/reveh.2003.18.1.1     Document Type: Review

References (84)

1. Lawrence DA, Kim D. Central/peripheral nervous system and immune responses. Toxicology 2000; 142:189-201.
2. Todd P, Pecaut MJ, Fleshner M. Combined effects of space flight factors and radiation on humans. Mutat Res 1999; 430: 211-219.
3. Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, et al. Soluble TNF-α receptor I and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 2001; 107: 165-170.
4. Schmitt DA, Peres C, Sonnenfeld G, Tkackzuk J, Arquier M, Mauco G, Ohayon E. Immune responses in humans after 60 days of confinement. Brain Behav Immun 1995; 9: 70-77.
5. Cogoli A. The effect of hypogravity and hypergravity on cells of the immune system. J Leukoc Biol 1993; 54: 259-68.
6. Giron, DJ, Pindak, FF, Schmidt JP. Effect of a space cabin environment on viral infection. Aerosp Med 1967; 38: 832-834.
7. Morey E, Sabelman E, Turner R, Baylink D. A new rat model simulating some aspects of spaceflight. The Physiologist 1979; 22: S23-S24.
8. Ilyan EA, Novikovo VE. A stand for simulation of physiological effects of weightlessness in laboratory experimental rats. Space Biot Med 1980; 14: 128-129.
9. Musacchia XJ, Deavers DR, Meininger GA, Davis TP. A new model for hypokinesia: effects on muscle atrophy in the rat. J Appl Physiol 1980; 48: 470-476.
10. Konstantinova IV, Fuchs BB. The Immune System in Space and Other Extreme Conditions. Chur, Switzerland: Harwood Academic Publishers, 1991.
11. Schmitt DA, Schaffar L, Taylor GR, Loftin KC, Schneider VS, Koebel A., et al. Use of bed rest and head-down tilt to simulate space flight-induced immune system changes. J. Interferon Cytokine Res 1996; 16: 151-157.
12. Maccarrone M, Battista N, Meloni M, Bari M, Galleri G, Pippia P, et al. Creating conditions similar to those that occur during exposure of cells to microgravity induces apoptosis in human lymphocytes by 5-lipoxygenase-mediated mitochondrial uncoupling and cytochrome c release. J Leukoc Biol 2003; 73: 472-481.
13. Cogoli A, Valuchi-Morf M, Müller M, Breigleib W. The effect of hypogravity on human lymphocyte activation. Aviat Space Environ Med 1980; 51: 29-34.
14. Cogoli A, Tschopp A, Fuchs-Buslin P. Cell sensitivity to gravity. Science 1984; 225: 228-230.
15. Bechler H, Cogoli A, Cogoli-Greuter M, Müller O, Hunzinger E. Activation of microcarrier attached lymphocytes in microgravity. Biotechnol Bioeng 1992; 40: 991-996.
16. Cogoli A, Tschopp A. Lymphocyte reactivity during spaceflight. Immunol Today 1985; 6: 1-4.
17. Talas M., Batkai L, Stoger L, Nagy L, Hiros L, Konstantinova I. Results of space experiment program "Interferon". I. Production of interferon in vitro by human lymphocytes aboard space laboratory Solyut-6 ("Interferon I") and influence of space flight on lymphocyte functions of cosmonauts ("Interferon III"). Acta Microbiol 1983; 30: 53-61.
18. Limouse M, Manie S, Konstantinova I, Ferrua B, Shaffar L. Inhibition of phorbol ester-induced activation in microgravity. Exp Cell Res 1991; 197: 82-86.
19. Schmitt DA, Hatton JP, Emond C, Chaput D, Paris H, Levade T, et al distribution of protein kinase C in human leukocytes is altered in microgravity. FASEB J 1996; 10: 627-1634.
20. Chapes SK, Morrison DR, Guikema JA, Lewis ML, Spooner BS. Cytokine secretion by immune cells in space. J Leukocyte Biol 1992; 52: 104-110.
21. Armstrong JW, Gerren RA, Chapes SK. The effect of space and parabolic flight on macrophage hematopoesis and function. Exp Cell Res 1995; 216: 160-168.
22. Durnova GN, Kaplansky AS, Portugalov VV. Effect of a 22 day spaceflight on lymphoid organs of rats. Aviat Space Environ Med 1976; 47: 588-591.
23. Mandel AD, Balish E. Effect of spaeflight on cell mediated immunity. Aviat Space Environ Med 1977; 48: 1051-1057.
24. Gould CL, Lyte M, Williams JA, Mandel AD, Sonnenfeld G. Inhibition of interferon-gamma but normal interleukin-3 production from rats flown on the Space Shuttle. Aviat Space Environ Med 1987; 58: 983-986.
25. Sonnenfeld G, Mandel AD, Konstantinova IV, Taylor GR, Berry WD, Wellhausen SR, et al. Effects of spaceflight on levels and activity of immune cells. Aviat Space Environ Med 1990; 61: 648-653.
26. Sonnenfeld G, Mandel AD, Konstantinova IV, Berry WD, Taylor GR, et al. Spaceflight alters immune cell function and distribution. J Appl Physiol 1992; 73: 191 S-1 95S.
27. Shadduck RK, Nagabhushanam NG. Granulocyte colony stimulating factor. I. Response to acute granulocytopenia. Blood 1971; 38: 559-568.
28. Rykova MP, Sonnenfeld G, Lesnyak AT, Taylor GR, Meshkov DO, Mandel AD, et al. Effect of spaceflight on natural killer cell activity J Appl Physiol 1992; 73: 196S-200S.
29. Allebban Z, Ichiki AT, Gibson LA, Jones JB, Congdon CC, Lange RD. Effects of spaceflight on the number of rat peripheral blood leukocytes and lymphocyte subsets. J Leukoc Biol 1994; 55: 209-213.
30. Congdon CC, Allebban Z, Gibson LA, Kaplansky A, Strickland KM, Jago TL, et al. Lymphatic changes in rats flown on Spacelab Life Sciences-2. J Appl Physiol 1996; 81: 172-177.
31. Grove DS, Pishar SA, Mastro AM. The effect of a 10-day space flight on the function, phenotype, and adhesion molecule expression of splenocytes and lymph node lymphocytes. Exp Cell Res 1995; 219: 102-109.
32. Ichiki AT, Gibson LD, Jago TL, Strickland KM, Johnson DL, Lange RD, Allebban Z. Effect of spaceflight on rat peripheral blood leukocytes and bone marrow progenitor cells. J Leukoc Biol 1996; 60: 37-43.
33. Nash P, Konstantinova IV, Fuchs BB, Rakhmilevich A, Lesnyak A, Mastro AM. Effect of spaceflight on lymphocyte proliferation and interleukin-2 production. J Appl Physiol 1992; 73: 186S-190S.
34. Nash P, Mastro AM. Variable lymphocyte responses in rats after spaceflight. Exp Cell Res 1992; 202: 125-131.
35. Lesnyak A, Sonnenfeld G, Avery L, Konstantinova I, Rykova M, Meshkov D, Orlova T. Effect of SLS-2 spaceflight on immunologic parameters of rats. J Appl Phsyiol 1996; 81: 178-182.
36. Sonnenfeld G, Foster M, Morton D, Bailliard F, Fowler NA, Hakenewirth AM, et al. Spaceflight and development of immune responses. J Appl Physiol 1998; 85: 1429-1433.
37. Sonnenfeld G, Davis S, Taylor GR, Mandel AD, Konstantinova IV, Lesnyak A, et al. Effect of spaceflight on cytokine production and other immunologic parameters of rhesus monkeys. J 1FN Cytokine Res 1996; 16: 409-415.
38. Pecaut MJ, Nelson GA, Peters LL, Kostenuik PJ, Bateman TA, Morony S, et al. Effects of spaceflight on immunity in the C57BL/6 mouse. I. Immune population distributions. J Appl Physiol 2003; 94: 2085-2094.
39. Gridley DS, Nelson GA, Peters LL, Kostenuik PJ, Bateman TA, Morony S, et al. Effect of spaceflight on immunity in the C57BL/6 mouse. II. Activation, cytokines, erythrocytes and platelets. J Appl Physiol 2003; 94: 2095-2103.
40. Taylor GR. Overview of spaceflight immunology studies. J Leukoc Biol 1993; 54: 179-188.
41. Taylor GR. NASA Technical Memorandum 58252, NASA, Washington, DC, USA, 1983; 35-48.
42. Taylor GR, Dardano JR. Human cellular immune responsiveness following spaceflight. Aviat Space Environ Med 1983; 54 Supp. 1: S55-S59.
43. Taylor GR, Neal LS, Dardano JR. Immunological analyses of U.S. Space Shuttle crewmembers. Aviat Space Environ Med 1986; 57: 213-217.
44. Meehan RT, Neale LS, Kraus ET, Stuart CA, Smith ML, Cintron NM, Sams CF. Alterations in human mononuclear leukocytes following spaceflight. Immunology 1992; 76: 491-497.
45. Meehan RT, Whitson P, Sams C. The role of pyschoneuroendocrine factors on spaceflight-induced immunological alterations. J Leukocyte Biol 1993; 54: 236-244.
46. Stowe RP, Sams CF, Mehta SK, Kaur I, Jones ML, Feeback DL, Pierson DL. Leukocyte subsets and neutrophil function after short-term spaceflight. J Leukoc Biol 1999; 65:179-186.
47. Crucian BE, Cubbage ML, Sams CF. Altered cytokine production by specific human peripheral blood cell subsets immediately following space flight. J Interferon Cytokine Res 2000; 20: 547-556.
48. Taylor GR, Janney RP. In vivo testing confirms a blunting of the human cell-mediated immune mechanism during spaceflight. J. Leukoc Biol 1992; 51: 129-132.
49. Gmünder FK, Konstantinova I, Cogoli A, Lesnyak A, Bogmolov W, Grachov AW. Cellular immunity in cosmonauts during long duration spaceflight on board the orbital MIR station. Aviat Space Environ Med 1994; 65: 419-423.
50. Hawkins W.R, Ziegelschmid JF. Clinical aspects of crew health. In: Johnston RS et al., eds, Biomedical Results of Apollo, NASA SP 368, NASA: Washington, DC, USA, 1975; 43-81.
51. Taylor GR. Recovery of medically important microorganisms from Apollo astronauts. Aerospace Med 1974; 45: 824-828.
52. Payne DA, Mehta SK, Tyring SK, Stowe RP Pierson DL. Incidence of Epstein-Barr virus in astronaut saliva during spaceflight. Aviat Space Environ Med 1999; 70: 1211-1213.
53. Stowe RP, Pierson DL, Barrett AD. Elevated stress hormone levels relate to Epstein-Barr virus reactivation in astronauts. Psychosom Med. 2001; 63: 891-895.
54. Stowe RP, Mehta SK, Ferrando AA, Feeback DL, Pierson DL. Immune responses and latent herpes virus reactivation in spaceflight. Aviat Space Environ Med 2001; 72: 884-891.
55. Vilchez RA, Madden CR, Kozinetz CA, Halvorson SJ, White ZS, Jorgensen JL, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359: 817-823.
56. Voss Jr, EW. Prolonged weightlessness and humoral immunity. Science 1984; 225: 214-215.
57. Steffen JM, Musacchia XJ. Thymic involution in the suspended rat: adrenal hypertrophy and glucocorticoid receptor content. Aviat Space Environ Med 1986; 57: 162-167.
58. Caren LD, Mandel AD, Nunes JA. Effect of simulated weightlessness on the immune system in rats. Aviat Space Environ Med 1984; 51: 251-255.
59. Rose A, Steffen JM, Musacchia XJ, Mandel AD, Sonnenfeld G. Effect of antiorthostatic suspension on interferon-alpha/beta production by the mouse. Proc Soc Exp Biol Med 1984; 177: 253-256.
60. Berry WD, Murphy JD, Smith BA, Taylor GR, Sonnenfeld G. Effect of microgravity modeling on interferon and interleukin responses in the rat. J Interferon Res, 1991; 11: 243-249.
61. Fleming SD, Rosenkrans CF Jr, Chapes SK. Test of the antiorthostatic suspension model on the inflammatory cell responses. Aviat Space Environ Med 1990; 61: 327-332.
62. Nash P, Bour B, Mastro AM. Effect of hindlimb suspension simulation of microgravity on in vitro immunological responses. Exp Cell Res 1991; 195: 353-360.
63. Pecaut MJ, Simske SJ, Fleshner M. Spaceflight induces changes in splenocyte subpopulations: effectiveness of ground-based models. Am J Physiol Regul Integr Comp Physiol. 2000; 279: R2072-R2078.
64. Gould CL, Sonnenfeld G. Enhancement of viral pathogenesis in mice maintained in an anti-orthostatic model: coordination with effects on interferon production. J Biolog Regulat Homeostat Mech 1987; 1: 33-36.
65. Miller ES, Sonnenfeld G. Influence of antiorthostatic suspension on resistance to murine Listeria monocytogenes infection. J Leukoc Biol 1994; 55: 371-378.
66. Miller ES, Sonnenfeld G. Influence of suspension on the expression of protective immunological memory to murine Listeria monocytogenes infection. J Leukoc Biol 1993; 54: 378-383.
67. Belay T, Aviles H, Vance M, Fountain K, Sonnenfeld G. Effects of the hindlimb unloading model of space flight conditions on resistance of mice to infection with Klebsiella pneumoniae. J Allergy Clin Immunol 2002; 110: 262-268.
68. Aviles HO, Belay T, Fountain K, Vance M, Sonnenfeld, G. Increased susceptibility to Pseudomonas aeruginosa infection under hindlimb unloading conditions. J Appl Physiol. 2003 [epub ahead of print] http://jap.physiology.org/cgi/reprint/00968.2002
69. Kajioka EH, Andres ML, Li M, Mao XW, Moyers MF, Nelson GA, Slater JM, Gridley DS. Acute effects of whole-body proton irradiation on the immune system of the mouse. RadiatRes 200; 153: 587-594.
70. Moore FD. Radiation burdens for humans on prolonged exomagnetospheric voyages. FASEB J 1992; 6: 2338-2343.
71. Kajioka EH, Gheorghe C, Andres ML, Abell GA, Folz-Holbeck J, Slater JM, et al. Effects of proton and gamma radiation on lymphocyte populations and acute response to antigen. In Vivo 1999; 13: 525-533.
72. Kajioka EH, Andres ML, Mao XW, Moyers MF, Nelson GA, Gridley DS. Hematological and TGF-β variations after whole-body proton irradiation. In Vivo 2000; 14: 703-708.
73. Gridley DS, Pecaut MJ, Dutta-Roy R, Nelson GA. Dose and dose rate effects of whole-body proton irradiation on leukocyte populations and lymphoid organs: part I. Immunol Lett 2002; 80: 55-66.
74. Pecaut MJ, Gridley DS, Smith AL, Nelson GA. Dose and dose rate effects of whole-body proton irradiation on lymphocyte blastogenesis and hematological variables: part 11. Immunol Lett 2002; 80: 67-73.
75. Sonnenfeld G, Measel J, Loken MR, Degioanni J, Follini S, Gaivagno A, Montalbini M. Effects of isolation on interferon production, hematological and immunological parameters. J Interferon Res 1992;12:75-81.
76. Shearer WT, Lugg DJ, Rosenblatt HM, Nickolls PM, Sharp RM, Reuben JM, Ochs HD. Antibody responses to bacteriophage φX-174 in human subjects exposed to the antarctic winter-over model of spaceflight. J Allergy Clin Immunol 2001; 107: 160-164.
77. Shearer WT, Lee BN, Cron SG, Rosenblatt HM, Smith EO, Lugg DJ, et al. Suppression of human anti-inflammatory plasma cytokines IL-10 and IL-IRA with elevation of proinflammatory cytokine IFN-gamma during the isolation of the Antarctic winter. J Allergy Clin Immunol 2002; 109: 854-857.
78. Shirai T, Magara KK, Motohashi S, Yamashita M, Kimura M, Suwazomo Y, et al. TH1-biased immunity induced by exposure to Antarctic winter. J Allergy Clin Immunol (in press).
79. Mehta SK, Pierson DL, Cooley H, Dubow R, Lugg D. Epstein-Barr virus reactivation associated with diminished cell-mediated immunity in Antarctic expeditioners. J Med Virol 2000; 61: 235-240.
80. O'Sullivan CE, Peng RS, Cole KS, Montelaro RC, Sturgeon T, Jenson, HB Ling PD. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. J Med Virol 2002; 67: 320-326.
81. Lednicky JA, Vilchez RA, Keitel WA, Visnegarwala F, White ZS, Kozinetz CA, et al. Polyoma virus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS 2003; 17: 801-807.
82. Ling PD, Lednicky JA, Keitel WA, Poston DG, White ZS, Peng RS, et al. The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis (in press).
83. Walling DM, Brown AL, Etienne W, Keitel WA Ling PD. Multiple Epstein-Barr virus infections in healthy individuals. J Virol (in press).
84. Ling PD, Vilchez RA, Keitel WA, Poston DA, Peng RS, White ZS, et al. Epstein-Barr virus DNA loads in adult HIV-infected patients receiving highly active antiretroviral therapy. (unpublished